SCMP

Sucampo completes enrollment in two Phase III OBD trials - 12/03 - 09:23 PM ET

Sucampo Completes Enrollment in Phase 3 Pivotal Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction - 12/02 - 04:05 PM ET

BRIEF-Sucampo reports Q3 results - 11/12 - 08:57 PM ET

Sucampo Reports Results for the Third Quarter of 2008 - 11/12 - 04:16 PM ET

SCMP: Q3 Earnings Call @ 17:00 ET Today [delayed] - 11/12 - 02:21 PM ET

Sucampo to Host Third Quarter 2008 Financial Results Conference Call on November 12, 2008 - 11/05 - 08:15 AM ET

Sucampo Europe reports positive data from constipation trials - 10/22 - 01:12 PM ET

Sucampo Pharmaceuticals names new head of sales and marketing - 10/20 - 10:32 AM ET

Sucampo Names Stanley G. Miele Head of Sales & Marketing - 10/16 - 04:10 PM ET

SCMP: To Present At UBS Global Life Sciences Conference @ 13:30 ET [delayed] - 09/25 - 11:53 AM ET

Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at UBS Conference - 09/23 - 04:10 PM ET

Sucampo reports positive results from Phase IIb constipation trial - 09/19 - 10:53 AM ET

Sucampo Pharmaceuticals names new head of business development - 09/04 - 12:50 PM ET

Sucampo Pharmaceuticals Limited Appoints New Head of Business Development - 09/02 - 04:10 PM ET

Sucampo names new board member - 08/28 - 12:07 PM ET

Sucampo Pharmaceuticals Strengthens Its Board of Directors - 08/27 - 04:15 PM ET

Sucampo Pharmaceuticals names new vice president - 08/26 - 11:23 AM ET

Sucampo Pharmaceuticals Appoints Kathryn de Santis as Vice President, Investor Relations and Corporate Communications - 08/25 - 04:15 PM ET

SCMP: Q2 Earnings Call @ 10:00 ET Today [delayed] - 08/18 - 07:20 AM ET

Sucampo Pharmaceuticals Reports Financial Results for the Second Quarter of 2008 - 08/14 - 07:00 AM ET

Page 1 of 4     1  2   3   4      Previous  |  Next

<< Back to Stock Index